🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, non-randomized, single-institution, single arm Phase...
Status
Active Not Recruiting
Location
University of Colorado Hospital
Start Date
2020-01-28
Trial ID
NCT04028063
Treatments Being Tested
This is an open-label, Phase 1/2, multicenter study to evaluate the safety,...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2016-04
Trial ID
NCT02694822
Treatments Being Tested
This is a phase II trial to evaluate the tolerability, efficacy, and immune...
Status
Terminated
Location
Mays Cancer Center
Start Date
2020-10-14
Trial ID
NCT04430036
Treatments Being Tested
This Phase 2, open-label study is designed to examine the efficacy and safe...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-02
Trial ID
NCT04607200
This is a Phase 1/2, open-label study of zalifrelimab (AGEN1884) in combina...
Status
Completed
Location
Comprehensive Care and Research Center
Start Date
2017-12-18
Trial ID
NCT03495882
Treatments Being Tested
A Phase IIa Open-Label Trial to Investigate the Safety, Tolerability, Pharm...
Status
Terminated
Location
Mater Research
Start Date
2017-10-04
Trial ID
NCT03411473
Treatments Being Tested
This is a randomized, blinded, non-comparative, two-arm Phase 2 clinical tr...
Status
Terminated
Location
University of Alabama at Birmingham School of Medicine
Start Date
2019-06-01
Trial ID
NCT03894215
This is an expanded access study for cancer treatment with balstilimab alon...
Status
Available
Location
University of Alabama at Birmingham
Start Date
TBD
Trial ID
NCT05572970
Treatments Being Tested